Laboratory Corporation of America Holdings at JPMorgan Healthcare Conference Transcript
All right. Thank you, everybody. I'm Casey Woodring from Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to introduce the management team of Labcorp. We have CEO, Adam Schechter; and CFO, Glenn Eisenberg. They're going to make some opening remarks, and then we're going to shift over to a fireside chat for the next 40 minutes. If you'd like to ask a question, please feel free to raise your hand. We have mic runners around the room. Or if you're on the webcast, feel free to submit via the conference portal. So with that, I'll hand it over to Adam.
All right. Thank you, Casey. Good afternoon, everybody. For those of you joining us by webcast, it's a pleasure to be here today. It's nice to be back in person after 3 years.
2022 was a pivotal year for Labcorp. We made significant strategic decisions. For example, we decided to spin our Clinical Development
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |